New glioblastoma cancer vaccine shows promise in phase 2 trial
Monday, June 6, 2011 - 09:00
in Health & Medicine
The first results of a multicenter Phase 2 clinical trial on a new brain cancer vaccine tailored to a patient's own tumor will be announced on Monday at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago.